Cargando…
Intravenous thrombolysis before endovascular therapy for large vessel strokes can lead to significantly higher hospital costs without improving outcomes
BACKGROUND: Limited efficacy of IV recombinant tissue plasminogen activator (rt-PA) for large vessel occlusions (LVO) raises doubts about its utility prior to endovascular therapy. PURPOSE: To compare outcomes and hospital costs for anterior circulation LVOs (middle cerebral artery, internal carotid...
Autores principales: | Rai, Ansaar T, Boo, SoHyun, Buseman, Chelsea, Adcock, Amelia K, Tarabishy, Abdul R, Miller, Maurice M, Roberts, Thomas D, Domico, Jennifer R, Carpenter, Jeffrey S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5749313/ https://www.ncbi.nlm.nih.gov/pubmed/28062805 http://dx.doi.org/10.1136/neurintsurg-2016-012830 |
Ejemplares similares
-
A population-based incidence of M2 strokes indicates potential expansion of large vessel occlusions amenable to endovascular therapy
por: Rai, Ansaar T, et al.
Publicado: (2018) -
A population-based incidence of acute large vessel occlusions and thrombectomy eligible patients indicates significant potential for growth of endovascular stroke therapy in the USA
por: Rai, Ansaar T, et al.
Publicado: (2017) -
The ‘pit-crew’ model for improving door-to-needle times in endovascular stroke therapy: a Six-Sigma project
por: Rai, Ansaar T, et al.
Publicado: (2016) -
Intravenous thrombolysis upon flow restoration improves outcome in endovascular thrombectomy
por: Weller, Johannes M, et al.
Publicado: (2023) -
Perceived acceptable uncertainty regarding comparability of endovascular treatment alone versus intravenous thrombolysis plus endovascular treatment
por: Kaesmacher, Johannes, et al.
Publicado: (2023)